These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


841 related items for PubMed ID: 19660688

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P, Parry G, Dark JH, Macgowan GA.
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [Abstract] [Full Text] [Related]

  • 5. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL.
    Circulation; 2003 Oct 28; 108(17):2066-9. PubMed ID: 14568893
    [Abstract] [Full Text] [Related]

  • 7. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
    Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, Systrom DM, Bloch KD, Semigran MJ.
    Circulation; 2007 Jan 02; 115(1):59-66. PubMed ID: 17179022
    [Abstract] [Full Text] [Related]

  • 8. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
    Jaillard S, Larrue B, Deruelle P, Delelis A, Rakza T, Butrous G, Storme L.
    Ann Thorac Surg; 2006 Mar 02; 81(3):935-42. PubMed ID: 16488698
    [Abstract] [Full Text] [Related]

  • 9. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ.
    Circulation; 2007 Oct 02; 116(14):1555-62. PubMed ID: 17785618
    [Abstract] [Full Text] [Related]

  • 10. Nesiritide acutely increases pulmonary and systemic levels of nitric oxide in patients with pulmonary hypertension.
    Khush KK, De Marco T, Vakharia KT, Harmon C, Fineman JR, Chatterjee K, Michaels AD.
    J Card Fail; 2006 Sep 02; 12(7):507-13. PubMed ID: 16952783
    [Abstract] [Full Text] [Related]

  • 11. Sildenafil for primary and secondary pulmonary hypertension.
    Watanabe H, Ohashi K, Takeuchi K, Yamashita K, Yokoyama T, Tran QK, Satoh H, Terada H, Ohashi H, Hayashi H.
    Clin Pharmacol Ther; 2002 May 02; 71(5):398-402. PubMed ID: 12011826
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
    Lepore JJ, Maroo A, Bigatello LM, Dec GW, Zapol WM, Bloch KD, Semigran MJ.
    Chest; 2005 May 02; 127(5):1647-53. PubMed ID: 15888841
    [Abstract] [Full Text] [Related]

  • 13. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH, Huntley BK, Schirger JA, Cataliotti A, Burnett JC.
    J Am Soc Nephrol; 2006 Oct 02; 17(10):2742-7. PubMed ID: 16928803
    [Abstract] [Full Text] [Related]

  • 14. PDE-5 inhibitor donor intravenous preconditioning is superior to supplementation in standard preservation solution in experimental lung transplantation.
    Pizanis N, Milekhin V, Tsagakis K, Aleksic I, Kamler M, Jakob H.
    Eur J Cardiothorac Surg; 2007 Jul 02; 32(1):42-7. PubMed ID: 17482829
    [Abstract] [Full Text] [Related]

  • 15. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadaş B, Schermuly RT, Weissmann N, Seeger W, Grimminger F.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1488-96. PubMed ID: 15464333
    [Abstract] [Full Text] [Related]

  • 16. Sildenafil extends survival and graft function in a large animal lung transplantation model.
    Korom S, Hillinger S, Cardell M, Zhai W, Tan Q, Dutly A, Leskosek B, Weder W.
    Eur J Cardiothorac Surg; 2006 Mar 06; 29(3):288-93. PubMed ID: 16442298
    [Abstract] [Full Text] [Related]

  • 17. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
    Michaels AD, Chatterjee K, De Marco T.
    J Card Fail; 2005 Aug 06; 11(6):425-31. PubMed ID: 16105633
    [Abstract] [Full Text] [Related]

  • 18. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
    Kögler H, Schott P, Toischer K, Milting H, Van PN, Kohlhaas M, Grebe C, Kassner A, Domeier E, Teucher N, Seidler T, Knöll R, Maier LS, El-Banayosy A, Körfer R, Hasenfuss G.
    Circulation; 2006 Jun 13; 113(23):2724-32. PubMed ID: 16754798
    [Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
    Attinà TM, Malatino LS, Maxwell SR, Padfield PL, Webb DJ.
    J Hypertens; 2008 Mar 13; 26(3):501-7. PubMed ID: 18300861
    [Abstract] [Full Text] [Related]

  • 20. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.
    Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD.
    J Am Coll Cardiol; 2004 Dec 21; 44(12):2339-48. PubMed ID: 15607396
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 43.